Iwan Cahyo Santosa Putra

Mr. Iwan Cahyo Santosa Putra


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2022 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
WKWilliam Kamarullah
William Kamarullah
HPHawani Sasmaya Prameswari
Hawani Sasmaya Prameswari
MPMiftah Pramudyo
Miftah Pramudyo
MIMohammad Iqbal
Mohammad Iqbal
BTBadai Bhatara Tiksnadi
Badai Bhatara Tiksnadi

13 July 2020 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
JHJoshua Henrina
Joshua Henrina
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
SLSherly Lawrensia
Sherly Lawrensia
QHQuinta Febryani Handoyono
Quinta Febryani Handoyono
ACAlius Cahyadi
Alius Cahyadi

22 August 2024 in Arrhythmia and Electrophysiology Review
Verified
Journal Article
Open access
PDF file
MIMohammad Iqbal
Mohammad Iqbal
WKWilliam Kamarullah
William Kamarullah
RPRaymond Pranata
Raymond Pranata
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
GKGiky Karwiky
Giky Karwiky
YKYoung-Hoon Kim
Young-Hoon Kim
The recently established non-thermal, single-shot pulsed field ablation (PFA) is a potential tool for achieving rapid pulmonary vein isolation (PVI) to cause cell death by electroporation, yet data regarding this state-of-the-art technology remain sparse. In this meta-analysis, we included 3,857 patients from 20 studies. There was no significant difference in AF recurrence between the PFA and control groups. Subgroup analysis showed that additional ablation beyond PVI has a similar rate of AF recurrence to PVI alone (10% versus 13%, respectively). PVI durability was achieved in 83% (mean), 95% CI [65–99%] of the PFA group and in 79% (mean), 95% CI [60–98%] of the control group, with no significant difference in the rate of PVI durability between the two groups. The PFA group had considerably reduced procedure duration, but not fluoroscopy time. No statistically significant differences in periprocedural complications were observed. PFA is associated with shorter procedural time than thermal ablation. Cardiac complications were uncommon and mainly reversible in both the PFA and control groups.

1 January 2021 in Thrombosis Update
Verified
Journal Article
Open access
JHJoshua Henrina
Joshua Henrina
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
ICIrvan Cahyadi
Irvan Cahyadi
SLSherly Lawrensia
Sherly Lawrensia
HGHoo Felicia Hadi Gunawan
Hoo Felicia Hadi Gunawan
LSLeonardo Paskah Suciadi
Leonardo Paskah Suciadi
Venous thromboembolism is prevalent in hospitalized COVID-19 patients. Through systematic review and meta-analysis, we have investigated the differences in clinical characteristics and outcome of hospitalized COVID-19 patients with (+) and without (-) venous thromboembolism (VTE). 45 studies with a total of 8859 patients were included in the qualitative synthesis. Subsequently, 38 studies with a total of 7847 patients, were quantitatively analysed. There was no mortality difference between the VTE (-) and VTE (+) hospitalized COVID-19 patients (RR1.32 (0.97, 1.79); 0.07; I2 64%, p<0.001). Patients with VTE (+) were more likely to get admitted to the intensive care unit (RR1.77 (1.26, 2.50); p<0.001; I2 63%, p= 0.03) and mechanically ventilated (RR 2.35 (1.22, 4.53); p=0.01; I2 88%, p<0.001). Moreover, male gender (RR 1.19 (1.14,1.24), p<0.001; I2 0%, p=0.68), increased the risk of VTE. Regarding patients lab values’, VTE (+) was significantly associated with higher white blood cell, neutrophil count, D-Dimer, alanine aminotransferase (ALT), lactate dehydrogenase (LDH), and C-reactive protein (CRP), along with prolonged prothrombin time. On the contrary, VTE (+) was associated with lower albumin and neutrophil-lymphocyte ratio (NLR). This findings provide the initial framework for risk stratification of hospitalized COVID-19 patients with VTE.

28 April 2022 in Indian Heart Journal
Verified
Journal Article
Open access
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
CIChristian Bobby Irianto
Christian Bobby Irianto
WRWilson Matthew Raffaello
Wilson Matthew Raffaello
LSLeonardo Paskah Suciadi
Leonardo Paskah Suciadi
HPHawani Sasmaya Prameswari
Hawani Sasmaya Prameswari
The outcome of this review is to assess the association between pre-pregnancy obesity and PPCM incidence. There were a total of 5.373.581 participants were included in this study. Pre-pregnancy obesity was significantly associated with PPCM incidence compared to normal-weight subjects (OR = 1.79 (1.16,2.76); p = 0.008; I2 = 59%, Pheterogeneity = 0.04). The sub-group analysis showed that pre-pregnancy women with obesity class I (OR = 1.58 (1.20,2.07); p = 0.001; I2 = 0%, Pheterogeneity = 0.64) and class II and III (OR = 2.65 (2.04,3.45); p < 0.001; I2 = 6%, Pheterogeneity = 0.36) was significantly associated with PPCM incidence compared to normal-weight subjects.

18 September 2024 in ESC Heart Failure
Verified
Journal Article
Open access
HPHawani Sasmaya Prameswari
Hawani Sasmaya Prameswari
WKWilliam Kamarullah
William Kamarullah
RPRaymond Pranata
Raymond Pranata
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
AUAlberta Claudia Undarsa
Alberta Claudia Undarsa
AAAstri Astuti
Astri Astuti
Aims: Peripartum cardiomyopathy (PPCM) may result in a number of detrimental adverse cardiovascular events, notably persistent left ventricular ejection fraction (LVEF) reduction or even mortality. Imaging parameters on cardiac magnetic resonance (CMR) and their prognostic implications have rarely been perused in PPCM. We aimed to describe CMR’s prognostic value in predicting poor left ventricular (LV) function recovery using late gadolinium enhancement (LGE) and T2-weighted or T2 mapping. Methods and results: PubMed, Europe PMC, and ScienceDirect were screened for studies on late gadolinium enhancement (LGE) and myocardial oedema using CMR and PPCM. The outcome of interest was poor LV function recovery, with a follow-up period of at least 6 months. Comparisons between groups with the presence of LGE, myocardial oedema, and recovered against non-recovered patients were pooled. A random-effects model was employed to calculate the effect size. All pooled results were expressed as risk ratios (RRs) and 95% confidence intervals (CI). The area under the curve (AUC) was generated to test overall prognostic accuracy. Six cohort studies with 162 patients were included. The mean age of participants in this study was 30.6 years, and the majority of patients were diagnosed with PPCM after delivery. LGE was associated with a higher risk of poor LV function recovery, particularly when conducted at a later stage of disease (≥2.8 months) [RR = 2.83 (95% CI = 1.25–6.40); P = 0.001]. On the contrary, CMR conducted early (<2.8 months) exhibited a greater predictive value for myocardial oedema perceived by T2 mapping [RR = 3.44 (95% CI = 1.04–11.34); P = 0.043]. Diagnostic-test accuracy meta-analysis revealed that LGE had a sensitivity of 73% (95% CI, 56–85%), specificity of 79% (95% CI, 45–95%), and AUC of 0.78 (95% CI, 0.75–0.82) in predicting poor LV recovery when performed in the later phase, whereas significant myocardial oedema in those with non-recovered LV function had a sensitivity of 12% (95% CI, 2–52%), specificity of 68% (95% CI, 39–88%), and AUC of 0.40 (95% CI, 0.36–0.44) while undertaken in the latter phase. Our findings support the notion that inflammation plays a significant role in PPCM and that alterations to tissue composition occur in a time-dependent manner. Conclusions: Contrast-enhanced CMR can be utilized as an adjunct examination in post-partum PPCM patients to stratify the risk of poor LV function recovery while conducted at a suitable point in time.